Apollo Green, a Biortica Agrimed Company, has been leading the supply of cannabis genetics in the Canadian and international markets for many years. Following the acquisition last year by Biortica Agrimed the company undertook a full review of the industry and concluded that the ACMPR platform needed to be updated to meet the needs of patients in the Canadian market.

Apollo Green has been a prominent figure in the Canadian cannabis genetics landscape for many years and has taken a significant stride forward with the relaunch of a new ACMPR platform tailored specifically for personal production licence holders in Ontario and Quebec.

The Apollo Green ACMPR platform offers a seamless and user-friendly purchasing experience, allowing licenced cultivators to browse, select and purchase with ease. Cultivators can choose from a wide variety of strains, ensuring access to the genetic diversity necessary to cultivate cannabis that suits individual medical needs.

“The ACMPR provides patients that are approved by their health care provider the option of producing their own cannabis at home for medical purposes. This plays an important role in meeting the needs of patients who prefer to grow themselves rather than source through other channels” said Matthew Turner, CEO of Apollo Green. “The refresh and relaunch of the Apollo Green ACMPR platform gives customers a new, fresh and easy to navigate portal while bringing some amazing genetics to patients in the Canadian market”

This relaunch platform accompanied with Apollo Green’s innovative delivery system is poised to transform the way medicinal cannabis patients in these regions access premium clones and seeds under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

“The relaunch of our ACMPR platform marks a significant milestone in our commitment to empowering individual patients and advancing the Canadian cannabis genetics industry. However, this also highlights our experience in working in markets that have medicinal, grow at home and adult use segments such as Canada and positions the wider Biortica Agrimed to respond to changes in the Australian Cannabis industry in the future.” Remarked Tom Varga, CEO of Biortica Agrimed. “Working with regulators in Australia I can see that if the market allowed for home grown Australian cannabis, then Apollo Green Australia and Green Farmers would be immediately ready to supply legal, clean and tested genetics to home growers tomorrow. That is very exciting!”

“We are excited to provide personal production licence holders with a comprehensive solution that simplifies the process of acquiring high-quality clones and seeds,” added Oisin Tierney, Sales Director for Apollo Green.